U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06860750) titled 'A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis' on March 02.
Brief Summary: The study is being conducted to evaluate the efficacy and safety of SHR-1314 injection in adult patients with active non-radiographic axial spondyloarthritis.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Active Non-radiographic Axial Spondyloarthritis
Intervention:
DRUG: SHR-1314 Injection
SHR-1314 injection.
DRUG: SHR-1314 Placebo Injection
SHR-1314 placebo injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Published ...